A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications

Clinical trial NCT03018405 · UNKNOWN

Trial details

NCT number: NCT03018405
Sponsor: Celyad Oncology SA
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia/Myelodysplastic Syndrome Multiple Myeloma (MM)

Start date: 2016-12-01
Primary completion: 2021-05-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.